<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1522" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1522/" /><meta name="ncbi_pagename" content="Birt-Hogg-Dubé Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Birt-Hogg-Dubé Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Birt-Hogg-Dubé Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/08/07" /><meta name="citation_author" content="Jorge R Toro" /><meta name="citation_pmid" content="20301695" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1522/" /><meta name="citation_keywords" content="Folliculin" /><meta name="citation_keywords" content="FLCN" /><meta name="citation_keywords" content="Birt-Hogg-Dube Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Birt-Hogg-Dubé Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jorge R Toro" /><meta name="DC.Date" content="2014/08/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1522/" /><meta name="description" content="The clinical characteristics of Birt-Hogg-Dubé syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, trichodiscomas/angiofibromas, perifollicular fibromas, and acrochordons), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear during the third and fourth decades of life and typically increase in size and number with age. Lung cysts are mostly bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that are typically bilateral and multifocal and usually slow growing; median age of tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (so-called oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor and/or autosomal dominant spontaneous pneumothorax without cutaneous manifestations." /><meta name="og:title" content="Birt-Hogg-Dubé Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="The clinical characteristics of Birt-Hogg-Dubé syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, trichodiscomas/angiofibromas, perifollicular fibromas, and acrochordons), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear during the third and fourth decades of life and typically increase in size and number with age. Lung cysts are mostly bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that are typically bilateral and multifocal and usually slow growing; median age of tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (so-called oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor and/or autosomal dominant spontaneous pneumothorax without cutaneous manifestations." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1522/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bhd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1522/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C7702E03F7D81000000000B1B03BF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1522_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1522_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/biotin/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bpes/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1522_"><span class="title" itemprop="name">Birt-Hogg-Dub&#x000e9; Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Jorge R Toro</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1522_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1522_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jorge R Toro</span>, MD<div class="affiliation small">Genetic Epidemiology Branch<br />Division of Cancer Epidemiology and Genetics<br />National Cancer Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@jorot" class="oemail">vog.hin.liam@jorot</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 27, 2006</span>; Last Update: <span itemprop="dateModified">August 7, 2014</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bhd.Summary" itemprop="description"><h2 id="_bhd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The clinical characteristics of Birt-Hogg-Dub&#x000e9; syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, trichodiscomas/angiofibromas, perifollicular fibromas, and acrochordons), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear during the third and fourth decades of life and typically increase in size and number with age. Lung cysts are mostly bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that are typically bilateral and multifocal and usually slow growing; median age of tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (so-called oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor and/or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> spontaneous pneumothorax without cutaneous manifestations.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>BHDS is diagnosed by clinical findings and by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. <i>FLCN</i> (also known as <i>BHD</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with BHDS. Sequence analysis detects pathogenic variants in <i>FLCN</i> in 88% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families, whereas 3%-5% have partial- or whole-gene deletions identified by other methods. Therefore, approximately 7%-9% of affected individuals who fulfill clinical diagnostic criteria do not have an identifiable <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Laser ablation of folliculoma/trichodiscoma results in substantial improvement for a period of time, but relapse usually occurs. Pneumothoraces are treated as in the general population. When possible, nephron-sparing surgery is the treatment of choice for renal tumors, depending on their size and location.</p><p><i>Surveillance:</i> Periodic MRI of the kidneys is the optimal screening modality to assess for kidney lesions; abdominal/pelvic CT scan with contrast is an alternative when MRI is not an option, but the long term effects of cumulative radiation exposure is unknown; full body skin examination at routine intervals to evaluate for melanoma should be considered.</p><p><i>Agents/circumstances to avoid:</i> Cigarette smoking, high ambient pressures, and radiation.</p><p><i>Evaluation of relatives at risk:</i> Molecular genetic testing for the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> for early identification of at-risk family members improves diagnostic certainty and reduces costly screening procedures in at-risk relatives who have not inherited the family-specific pathogenic variant.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>BHDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The offspring of an individual with BHDS have a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal diagnosis for pregnancies at increased risk is possible if the <i>FLCN</i> pathogenic variant of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member has been identified.</p></div></div><div id="bhd.Diagnosis"><h2 id="_bhd_Diagnosis_">Diagnosis</h2><div id="bhd.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Three major features characterize Birt-Hogg-Dub&#x000e9; syndrome (BHDS):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Cutaneous manifestations.</b> Individuals with BHDS usually present with multiple, small, skin-colored, dome-shaped papules distributed over the face, neck, and upper trunk. The original characteristic dermatologic triad was fibrofolliculomas, trichodiscomas, and acrochordons [<a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>]; however, only fibrofolliculomas are specific for BHDS. Perifollicular fibromas and angiofibromas have also been associated with BHDS. Trichodiscomas are essentially histologically and clinically indistinguishable from angiofibromas; the term trichodiscoma has been used to describe angiofibromas when they occur in the setting of BHDS.</div><div class="half_rhythm">The dermatologic diagnosis of BHDS is made in individuals who have five or more facial or truncal papules with at least one histologically confirmed fibrofolliculoma [<a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>]:</div><ul><li class="half_rhythm"><div class="half_rhythm"><b>Fibrofolliculomas</b> are defined as multiple anastomosing strands of two to four epithelial cells extending from a central follicle. Sometimes a well-demarcated, mucin-rich, or thick connective tissue stroma encapsulates the epithelial component. Biopsy is required to make the diagnosis.</div><div class="half_rhythm">Note: Shave biopsy is usually not adequate. More than one skin-punch biopsy and sectioning of the paraffin-embeded block is sometimes needed to make the diagnosis of fibrofolliculoma.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Trichodiscomas</b> are hamartomatous lesions comprising a round to elliptically shaped well-demarcated proliferation of thick fibrous and vascular stroma in the reticular dermis with a hair follicle at the periphery. Because of the high density of hair follicles in the face, hair follicles are commonly found at the periphery of these lesions. <b>Angiofibromas</b> are clinically and histologically essentially the same as trichodiscomas.</div><div class="half_rhythm">Note: Trichodiscomas/angiofibromas are suggestive for the diagnosis of BHDS but not diagnostic. Angiofibromas are commonly also found in <a href="/books/n/gene/tuberous-sclerosis/">tuberous sclerosis complex</a> (TSC) and <a href="/books/n/gene/men1/">multiple endocrine neoplasia type 1</a> (MEN1).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Acrochordons,</b> or skin tags, are soft pedunculated papules that histologically are characterized by acanthotic and mild papillomatous epidermis with loose connective tissue stroma and blood vessels.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Perifollicular fibromas</b> are well-demarcated proliferations of fibrous and vascular stroma in the reticular dermis surrounding a hair follicle.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Lung cysts and spontaneous pneumothorax.</b> Most individuals (89%) with BHDS have multiple bilateral lung cysts, identified by high-resolution chest CT. The total number of lung cysts per individual ranges from 0 to 166 (mean 16). Forty-eight (24%) of 198 individuals with BHDS had a history of one or more pneumothoraces [<a class="bk_pop" href="#bhd.REF.toro.2007.1044">Toro et al 2007</a>].</div><ul><li class="half_rhythm"><div>All individuals with a history of pneumothorax had multiple lung cysts identified by high-resolution chest CT imaging. BHDS-related lung cysts abutted on interlobular septa (88.2%) and had intracystic septa (13.6%) or protruding venules (39.5%) without cell proliferation or inflammation. BHDS-related lung cysts are likely to develop in the periacina region where alveoli attach to connective tissue [<a class="bk_pop" href="#bhd.REF.kumasaka.2014.100">Kumasaka et al 2014</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Renal tumors.</b> The renal tumors are usually bilateral and multifocal. Histologic tumor types include: hybrid oncocytic renal cell carcinoma, oncocytoma, chromophobe renal cell carcinoma, and a minority of clear cell renal cell carcinoma. Note: <i>FLCN</i> nucleotide variants have been identified in certain tumors, see Molecular Genetics, <a href="#bhd.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</div></li></ul><p>Note: The original description and diagnosis of BHDS is based on skin pathology. However, recent investigations have shown that some individuals with BHDS could present with pulmonary involvement and/or renal tumors without skin lesions.</p></div><div id="bhd.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>FLCN</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause BHDS.</p><div id="bhd.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Birt-Hogg-Dub&#x000e9; Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1522/table/bhd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bhd.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLCN</i></td><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~53%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~88%</td></tr><tr><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_bhd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%-5%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bhd.TF.1.1"><p class="no_margin">See <a href="/books/NBK1522/#bhd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#bhd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="bhd.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#bhd.REF.schmidt.2005.1023">Schmidt et al [2005]</a>, <a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al [2008]</a></p></div></dd><dt>3. </dt><dd><div id="bhd.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="bhd.TF.1.4"><p class="no_margin">Pathogenic variants detected: Polycytosine tract <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (<a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285delC</a>) / <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (<a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285dupC</a>)</p></div></dd><dt>5. </dt><dd><div id="bhd.TF.1.5"><p class="no_margin">Twenty-seven (53%) of 51 families with BHDS were found to have <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (<a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285delC</a>) or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (<a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285dupC</a>) of a C nucleotide in the polycytosine tract in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11, which is a mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> (see <a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">Table 2</a>).</p></div></dd><dt>6. </dt><dd><div id="bhd.TF.1.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd></dl></div></div></div></div><div id="bhd.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Molecular genetic testing is indicated in all individuals known to have or suspected of having BHDS, including individuals with one of the following:</p><ul><li class="half_rhythm"><div>Five or more facial or truncal papules with at least one histologically confirmed fibrofolliculoma [<a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>], with or without a family history of BHDS</div></li><li class="half_rhythm"><div>Facial papules histologically confirmed to be angiofibroma in an individual who does not fit the clinical criteria of <a href="/books/n/gene/tuberous-sclerosis/">tuberous sclerosis complex</a> (TSC) or <a href="/books/n/gene/men1/">multiple endocrine neoplasia type 1</a> (MEN1)</div></li><li class="half_rhythm"><div>Multiple and bilateral chromophobe, oncocytic, and/or hybrid renal tumors</div></li><li class="half_rhythm"><div>A single oncocytic, chromophobe, or oncocytic hybrid renal tumor and a family history of renal cancer with any of the above renal cell tumor types</div></li><li class="half_rhythm"><div>A family history of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> primary spontaneous pneumothorax without a history of smoking or COPD</div></li></ul><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> One strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having BHDS is cascade testing of <i>FLCN</i>:</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Molecular genetic testing may start with <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11, as a majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have one of two pathogenic variants found in exon 11 (see <a class="figpopup" href="/books/NBK1522/table/bhd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbhdTmoleculargenetictestingusedin" rid-ob="figobbhdTmoleculargenetictestingusedin">Table 1</a>).</p></dd><dt>2.</dt><dd><p class="no_top_margin">If targeted <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 does not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, sequencing of the entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>FLCN</i> should be considered.</p></dd><dt>3.</dt><dd><p class="no_top_margin">If full-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> does not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>FLCN</i> may be considered.</p></dd></dl><p><b>Multigene panel.</b> Another strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having BHDS is a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes genes known to cause various features of the condition (see <a href="#bhd.Differential_Diagnosis">Differential Diagnosis</a>). These panels vary by methods used and genes included; thus, the ability of a panel to detect a causative allelic variant in any given individual with features of BHDS also varies. For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Exome sequencing.</b> In individuals with a clinical diagnosis of BHDS but in whom no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLCN</i> is identified, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> may be considered. For an introduction to exome sequencing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering exome sequencing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p></div></div><div id="bhd.Clinical_Characteristics"><h2 id="_bhd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bhd.Clinical_Description"><h3>Clinical Description</h3><p>The clinical characteristics of Birt-Hogg-Dub&#x000e9; syndrome (BHDS) include fibrofolliculomas (specific cutaneous lesions), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly among family members and between families.</p><p><b>Cutaneous lesions.</b> BHDS is associated with a spectrum of cutaneous hamartomas ranging from angiofibroma to perifollicular fibromas to fibrofolliculomas [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]. Families with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FLCN</i> can have angiofibromas (i.e., trichodiscomas), perifollicular fibroma, or both angiofibroma and perifollicular fibromas as their only cutaneous manifestations of BHDS [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]. Other individuals with BHDS develop oral papules and cutaneous collagenomas [<a class="bk_pop" href="#bhd.REF.nadershahi.1997.496">Nadershahi et al 1997</a>, <a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>]. Multiple epidermal cysts have been found in approximately 14% of individuals with BHDS [<a class="bk_pop" href="#bhd.REF.kluger.2010.527">Kluger et al 2010</a>].</p><p>The onset of skin lesions is typically during the third or fourth decade of life. Skin lesions tend to increase in size and number with age. Later onset of cutaneous lesions tends to correlate with a milder skin <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Women tend to have smaller and fewer lesions than men.</p><p>BHDS has been reported to be associated with cutaneous melanoma, including multiple desmoplastic melanomas [<a class="bk_pop" href="#bhd.REF.lindor.2001.653">Lindor et al 2001</a>, <a class="bk_pop" href="#bhd.REF.khoo.2002.906">Khoo et al 2002</a>, <a class="bk_pop" href="#bhd.REF.welsch.2005.668">Welsch et al 2005</a>, <a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>, <a class="bk_pop" href="#bhd.REF.sempau.2010.637">Sempau et al 2010</a>, <a class="bk_pop" href="#bhd.REF.cocciolone.2010.1316">Cocciolone et al 2010</a>, <a class="bk_pop" href="#bhd.REF.motaburgos.2013.323">Mota-Burgos et al 2013</a>] and choroidal melanoma [<a class="bk_pop" href="#bhd.REF.fontcuberta.2011.143">Fontcuberta et al 2011</a>]. Whether individuals with BHDS are at increased risk of developing melanoma compared to the general population requires further investigation.</p><p>A family with BHDS in which one sib developed a dermatofibrosarcoma protuberans (DFSP) and another sib had a cutaneous leiomyosarcoma has also been described [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>].</p><p><b>Pulmonary cysts and spontaneous pneumothorax.</b> Lung cysts are mostly bilateral and multifocal. Most individuals with BHDS and lung cysts are asymptomatic, but they have a high risk of developing spontaneous, often recurrent, pneumothorax. Clinical presentation of pneumothorax ranges from asymptomatic to dyspnea and chest pain. Clinical findings include tachypnea or decreased or absent breath sounds. Radiographic investigation may require a high-resolution CT of the chest to confirm the diagnosis of pneumothorax as chest x-ray may not be sensitive enough to detect a loculated pneumothorax.</p><p>In the recent study of <a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al [2008]</a>, 89% of individuals with a <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were found to have pulmonary cysts on chest CT, a rate that is higher than the 77% observed in all earlier reports combined.</p><p>In the same study of <a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al [2008]</a>, 38% of individuals with a <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were found to have a history of spontaneous pneumothorax, a rate similar to the 33% in all earlier reports combined.</p><p>Individuals with BHDS and a family history of pneumothorax have a statistically significant increased risk of pneumothorax compared to individuals with BHDS without a family history of spontaneous pneumothorax.</p><p>Individuals with BHDS have a 50-fold increased risk for spontaneous pneumothorax compared to family members who do not have BHDS [<a class="bk_pop" href="#bhd.REF.zbar.2002.393">Zbar et al 2002</a>].</p><p><b>Renal cysts and tumors.</b> In a French case series, renal ultrasound, CT scan and/or MRI revealed renal cysts in ten (45%) of 22 individuals with BHDS who did not have renal carcinoma diagnosed at the time of screening [<a class="bk_pop" href="#bhd.REF.kluger.2010.527">Kluger et al 2010</a>].</p><p>Approximately 70 individuals with <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and kidney tumors have been reported [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]. The most common tumors are a hybrid of oncocytoma and chromophobe histologic cell types, so-called oncocytic hybrid tumor (67%), chromophobe renal cell carcinoma (23%), and renal oncocytoma (3%). Only renal oncocytoma is considered a benign tumor [<a class="bk_pop" href="#bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</a>]. Other types of renal tumors reported in lower frequency include clear cell renal cell carcinoma and papillary renal carcinoma.</p><p>Most renal tumors associated with BHDS are bilateral, multifocal, and slow growing. Median age of diagnosis is 48 years, with a range from 31 to 71 years [<a class="bk_pop" href="#bhd.REF.schmidt.2005.1023">Schmidt et al 2005</a>].</p><p>Individuals with BHDS were at a sevenfold increased risk for renal tumors compared with their unaffected sibs [<a class="bk_pop" href="#bhd.REF.zbar.2002.393">Zbar et al 2002</a>]. Using combined ascertainment in dermatologic and urologic oncology clinics at the National Cancer Institute (NCI) at the National Institutes of Health (NIH), the overall prevalence of kidney tumors among individuals with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>FLCN</i> pathogenic variants was 29%-34% [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]. This high frequency &#x02013; compared to the 6.5% frequency of kidney tumors in BHDS cases determined from a combination of other investigators &#x02013; may reflect ascertainment bias.</p><p>The renal tumors associated with BHDS may affect morbidity more than mortality in persons with BHDS. Nephron-sparing surgery may decrease the morbidity associated with renal tumors by preserving functioning renal tissue because <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals usually develop multifocal and bilateral kidney tumors.</p><p>Renal oncocytosis observed at surgery or at postmortem examination is evidence of the potential of persons with BHDS to develop kidney tumors [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>].</p><p><b>Parotid oncocytoma.</b> The first case of an individual with BHDS who developed a parotid oncocytoma was reported in 2000 [<a class="bk_pop" href="#bhd.REF.liu.2000.1120">Liu et al 2000</a>]. Subsequently multiple cases have been reported [<a class="bk_pop" href="#bhd.REF.schmidt.2005.1023">Schmidt et al 2005</a>, <a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]. Additionally, one person with BHDS has been reported with a pleomorphic adenoma [<a class="bk_pop" href="#bhd.REF.palmirotta.2008.382">Palmirotta et al 2008</a>] and another individual with BHDS has been reported with a Warthin parotid tumor [<a class="bk_pop" href="#bhd.REF.maff_.2011.345">Maff&#x000e9; et al 2011</a>]. Two cases of bilateral parotid tumors have also been reported [<a class="bk_pop" href="#bhd.REF.maff_.2011.345">Maff&#x000e9; et al 2011</a>, <a class="bk_pop" href="#bhd.REF.lindor.2012.13">Lindor et al 2012</a>]. The frequency and the bilateral, multifocal nature of these tumors in individuals with BHDS who have not undergone specific screening for parotid tumors suggest that parotid tumors are a manifestation of BHDS.</p><p><b>Oral papules</b> have been reported in nine (43%) of 21 individuals with BHDS in a large French case series [<a class="bk_pop" href="#bhd.REF.kluger.2010.527">Kluger et al 2010</a>] and in several other reports [<a class="bk_pop" href="#bhd.REF.nadershahi.1997.496">Nadershahi et al 1997</a>, <a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>].</p><p><b>Other findings</b></p><ul><li class="half_rhythm"><div><b>Thyroid pathology.</b> Three cases of thyroid cancer in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>, <a class="bk_pop" href="#bhd.REF.kunogi.2010.281">Kunogi et al 2010</a>]. Multinodular goiter [<a class="bk_pop" href="#bhd.REF.drummond.2002.301">Drummond et al 2002</a>, <a class="bk_pop" href="#bhd.REF.welsch.2005.668">Welsch et al 2005</a>] and thyroid nodules and/or cysts have also been reported. In a French case series, thyroid nodules and/or cysts were detected by ultrasonography in 13 (65%) of 20 individuals with BHDS; no medullary carcinoma or other thyroid carcinomas were detected. None of the affected individuals with thyroid nodules and/or cysts had a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> history of thyroid cancer. Overall, nine (90%) of ten families affected by BHDS with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FLCN</i> had individuals with thyroid nodules [<a class="bk_pop" href="#bhd.REF.kluger.2010.527">Kluger et al 2010</a>].</div></li><li class="half_rhythm"><div><b>Colon cancer.</b> Multiple cases of colon cancer have been described in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>], but the evidence associating colonic neoplasm and BHDS is conflicting [<a class="bk_pop" href="#bhd.REF.khoo.2002.906">Khoo et al 2002</a>, <a class="bk_pop" href="#bhd.REF.zbar.2002.393">Zbar et al 2002</a>] (see <a href="#bhd.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a> and <a href="#bhd.Molecular_Genetics">Molecular Genetics</a>).</div></li><li class="half_rhythm"><div><b>Other tumor types</b> have been reported rarely in individuals with BHDS:</div><ul><li class="half_rhythm"><div>Squamous cell carcinoma of the head and neck [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>Hodgkin disease [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>Uterine cancer [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>Prostate cancer [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>Breast cancer [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>, <a class="bk_pop" href="#bhd.REF.kunogi.2010.281">Kunogi et al 2010</a>]</div></li><li class="half_rhythm"><div>Squamous cell carcinoma of the cervix [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>Rhabdomyoma [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>]</div></li><li class="half_rhythm"><div>An adrenal mass and adenoma of adrenal gland [<a class="bk_pop" href="#bhd.REF.toro.2008.321">Toro et al 2008</a>, <a class="bk_pop" href="#bhd.REF.kunogi.2010.281">Kunogi et al 2010</a>]</div></li><li class="half_rhythm"><div>Myoma of the uterus [<a class="bk_pop" href="#bhd.REF.kunogi.2010.281">Kunogi et al 2010</a>]</div></li><li class="half_rhythm"><div>Lipoma, angiolipoma, and collagenoma [<a class="bk_pop" href="#bhd.REF.toro.1999.1195">Toro et al 1999</a>]</div></li><li class="half_rhythm"><div>Cutaneous neural tumors: neurothekeoma (benign myxoma of cutaneous nerve sheath origin), meningioma [<a class="bk_pop" href="#bhd.REF.vincent.2003.717">Vincent et al 2003</a>] and multiple neurilemmomas [<a class="bk_pop" href="#bhd.REF.renfree.2012.792">Renfree &#x00026; Lawless 2012</a>]</div></li><li class="half_rhythm"><div>Ovarian cyst [<a class="bk_pop" href="#bhd.REF.godbolt.2003.52">Godbolt et al 2003</a>]</div></li><li class="half_rhythm"><div>Parathyroid adenoma [<a class="bk_pop" href="#bhd.REF.chung.1996.365">Chung et al 1996</a>]</div></li><li class="half_rhythm"><div>Chorioretinal lesions [<a class="bk_pop" href="#bhd.REF.walter.1997.359">Walter et al 1997</a>, <a class="bk_pop" href="#bhd.REF.godbolt.2003.52">Godbolt et al 2003</a>]</div></li><li class="half_rhythm"><div>Neuroendocrine carcinoma [<a class="bk_pop" href="#bhd.REF.claessens.2010.583">Claessens et al 2010</a>]</div></li></ul></li></ul></div><div id="bhd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations have been reported; whether these manifestations are truly associated with BHDS remains to be determined through larger studies.</p><p>No correlation is observed between the type of <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and pulmonary and cutaneous manifestations.</p><p>A previous study suggested that individuals with the <a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285delC</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be at lower risk of developing renal cancers than individuals with other <i>FLCN</i> pathogenic variants; this needs to be evaluated in large studies.</p><p>Analysis of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for two recurrent <i>FLCN</i> pathogenic variants identified in a subset of 51 families with BHDS demonstrated a significantly higher risk of colorectal neoplasia in those with the <a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.1285dupC</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (within the <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 C(8) mononucleotide tract) than in those with the <a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">c.610delGCinsTA</a> pathogenic variant (chi(2)=5.78, p=0.016) [<a class="bk_pop" href="#bhd.REF.nahorski.2010.385">Nahorski et al 2010</a>].</p></div><div id="bhd.Penetrance"><h3>Penetrance</h3><p>Based on the three major clinical manifestations, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of BHDS is considered to be very high.</p></div><div id="bhd.Anticipation"><h3>Anticipation</h3><p>Anticipation is not known to occur in BHDS.</p></div><div id="bhd.Nomenclature"><h3>Nomenclature</h3><p>Hornstein-Knickenberg syndrome (HK), which describes <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> multiple perifollicular fibromas, is considered to fall within the spectrum of BHDS [<a class="bk_pop" href="#bhd.REF.schulz.1999.55">Schulz &#x00026; Hartschuh 1999</a>].</p></div><div id="bhd.Prevalence"><h3>Prevalence</h3><p>More than 100 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families from various populations have been described.</p></div></div><div id="bhd.Genetically_Related_Allelic_Disorder"><h2 id="_bhd_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b>Autosomal dominant primary spontaneous pneumothorax.</b> Germline pathogenic variants in <i>FLCN</i> were found in families with dominantly inherited spontaneous pneumothorax. Pulmonary involvement appears to be the only manifestation; <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is 100% [<a class="bk_pop" href="#bhd.REF.graham.2005.39">Graham et al 2005</a>, <a class="bk_pop" href="#bhd.REF.painter.2005.522">Painter et al 2005</a>].</p></div><div id="bhd.Differential_Diagnosis"><h2 id="_bhd_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Cutaneous lesions.</b> Fibrofolliculomas are rare and specific for Birt-Hogg-Dub&#x000e9; syndrome (BHDS). Because fibrofolliculomas are clinically similar to various cutaneous lesions, histologic diagnosis is required.</p><p>Acrochordons, or skin tags, are nonspecific and are found in the general population.</p><p>BHDS-associated hamartomas should be distinguished from other genodermatoses with an increased risk for internal malignancy, including tuberous sclerosis complex (TSC), <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> trichoepitheliomas, <a href="/books/n/gene/men1/">MEN1</a>, and Cowden syndrome (see <a href="/books/n/gene/phts/"><i>PTEN</i> Hamartoma Tumor Syndrome</a>).</p><p><b>Pulmonary manifestation.</b> Several inherited and noninherited conditions can present with lung cysts and/or pneumothorax. A thorough history and physical examination help to differentiate these conditions from BHDS. These conditions include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/marfan/">Marfan syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/eds4/">Vascular Ehlers-Danlos syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/tuberous-sclerosis/">Tuberous sclerosis complex</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/alpha1-a/">Alpha1-antitrypsin deficiency</a> [<a class="bk_pop" href="#bhd.REF.daniel.2000.327">Daniel &#x00026; Teba 2000</a>]</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cf/">Cystic fibrosis</a> [<a class="bk_pop" href="#bhd.REF.flume.2005.720">Flume et al 2005</a>]</div></li><li class="half_rhythm"><div>Langerhan cell histiocytosis (OMIM <a href="http://www.omim.org/entry/604856" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604856</a>) [<a class="bk_pop" href="#bhd.REF.mendez.2004.1028">Mendez et al 2004</a>]</div></li><li class="half_rhythm"><div>Pulmonary lymphangioleiomyomatosis (LAM) (OMIM <a href="http://www.omim.org/entry/606690" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606690</a>) occurring as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding or as part of TSC</div></li></ul><p><b>Renal tumor.</b> Unlike BHDS, most <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> renal cancer syndromes are associated with different types of renal pathology [<a class="bk_pop" href="#bhd.REF.linehan.2005.2">Linehan et al 2005</a>]. Familial renal cancer syndromes and their renal pathology include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/vhl/">von Hippel-Lindau syndrome</a> (VHL syndrome). Bilateral and multifocal clear cell renal cell carcinomas. Individuals with VHL syndrome are also at risk for central nervous system hemangioblastoma, retinal angioma, pheochromocytoma, and endolymphatic sac tumors.</div></li><li class="half_rhythm"><div>Hereditary papillary renal cancer (HPRC). Bilateral and multifocal type 1 papillary renal cell carcinomas</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hlrcc/">Hereditary leiomyomatosis and renal cell cancer</a> (HLRCC). Usually solitary renal tumors with a histologic spectrum ranging from tubo-papillary renal cell cancer to type 2 papillary renal cancer to collecting duct renal cell cancer. Individuals with HLRCC can present with cutaneous leiomyoma and/or with early-onset and aggressive uterine fibroids.</div></li></ul></div><div id="bhd.Management"><h2 id="_bhd_Management_">Management</h2><div id="bhd.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Birt-Hogg-Dub&#x000e9; syndrome (BHDS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Detailed dermatologic examination and punch biopsy of suspected cutaneous lesion</div></li><li class="half_rhythm"><div>High-resolution computed tomography (HRCT) or CT of the chest highly recommended for visualization of pulmonary cysts. Individuals who have symptoms/signs of pneumothorax should immediately undergo chest x-ray and CT of the chest and appropriate treatment.</div></li><li class="half_rhythm"><div>Baseline abdominal/pelvic CT scan with contrast or MRI to screen for renal tumor. Renal ultrasound examination may distinguish cystic from solid renal lesions.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="bhd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>In general, fibrofolliculomas and trichodiscomas are benign lesions for which no treatment is required; however, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may seek treatment for such lesions for cosmetic purposes, particularly when multiple cutaneous lesions are located on the face. Treatment of fibrofolliculomas and trichodiscomas is difficult, as they tend to be numerous and recurring. Erbium-YAG or fractional CO<sub>2</sub> laser ablation may result in substantial improvement, but relapse can occur [<a class="bk_pop" href="#bhd.REF.gambichler.2000.856">Gambichler et al 2000</a>, <a class="bk_pop" href="#bhd.REF.jacob.2001.98">Jacob &#x00026; Dover 2001</a>, <a class="bk_pop" href="#bhd.REF.kahle.2001.43">Kahle et al 2001</a>]. Shaving or other ablative methods have been used with variable results.</p><p>Treatment of pneumothorax is the same as in the general population.</p><p>Nephron-sparing surgery is the treatment of choice for renal tumors whenever possible, depending on the size and location of the tumors [<a class="bk_pop" href="#bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</a>]. Because of the bilateral, multifocal nature of BHDS-associated kidney cancer, a management approach involving observation of small tumors until they reach 3.0 cm in size is often recommended [<a class="bk_pop" href="#bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</a>]. Therefore, renal tumors greater than 3.0 cm and/or rapidly growing tumors usually require partial nephrectomy. When surgical intervention is recommended, an attempt is made to remove all or most of the visible tumors. Although surgical management is not considered "curative" for BHDS-associated renal cell carcinoma (RCC), BHDS-associated renal tumors often are slow growing, and only infrequently are multiple surgical procedures required during a an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's lifetime to control the tumor burden and prevent the development of metastasis.</p></div><div id="bhd.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>No preventive or curative treatment is available for BHDS. However, development of renal cell carcinoma has the strongest positive association with cigarette smoking [<a class="bk_pop" href="#bhd.REF.moore.2005.240">Moore et al 2005</a>].</p></div><div id="bhd.Surveillance"><h3>Surveillance</h3><p>There is no consensus on clinical surveillance; the recommendations given are provisional until a consensus conference is conducted.</p><p>Individuals with known BHDS, individuals known to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLCN</i> without clinical manifestations, and at-risk family members who have not undergone genetic testing should have regular monitoring by physicians familiar with the spectrum of BHDS.</p><p><b>Renal tumor screening</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Renal imaging is appropriate for individuals age 18 years or older when the clinical diagnosis of BHDS is established or if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLCN</i> is confirmed. However, earlier testing and surveillance for renal tumors should be personalized based on family history of renal tumor development, when available.</div></li><li class="half_rhythm"><div class="half_rhythm">Yearly MRI of the kidneys is the optimal screening modality to assess for kidney lesions.</div><div class="half_rhythm">Abdominal/pelvic CT scan with contrast is an alternative when MRI is not an option. However, the long-term effects of cumulative radiation exposure in individuals with BHDS is unknown and has not been studied.</div></li><li class="half_rhythm"><div class="half_rhythm">As a result of the low aggressiveness of kidney tumors and the 3.0-cm rule used by surgeons in treating renal tumors [<a class="bk_pop" href="#bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</a>], <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals without a family history of kidney tumors who have had two to three consecutive annual MRI examinations without the detection of kidney lesions may be screened every two years until a suspicious lesion is identified.</div><div class="half_rhythm">Note: The use of renal ultrasound examination is helpful in further characterization of kidney lesions but should not be used as a primary screening modality.</div></li><li class="half_rhythm"><div class="half_rhythm">If any suspicious lesion (&#x0003c;1.0 cm in diameter, indeterminate lesion, or complex cysts) is noted on screening examination, annual MRI should be instituted. Abdominal/pelvic CT scan with contrast may be used as an alternative in those for whom MRI is not an option.</div></li><li class="half_rhythm"><div class="half_rhythm">Renal tumors &#x0003c;3.0 cm in diameter are monitor by periodic imaging. When the largest renal tumor reaches 3.0 cm in maximal diameter evaluation by a urologic surgeon is appropriate with consideration of nephron-sparing surgery [<a class="bk_pop" href="#bhd.REF.stamatakis.2013.397">Stamatakis et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Rapidly growing lesions and/or symptoms including pain, blood in the urine, or atypical presentations require a more individualized approach. PET-CT scan is an option for evaluation of these lesions.</div></li></ul><p><b>Melanoma.</b> Because of a concern for a possible increased risk of melanoma in those with BHDS, full body skin examination at routine intervals to evaluate for suspicious pigmented lesions should be considered.</p></div><div id="bhd.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Cigarette smoking</div></li><li class="half_rhythm"><div>High ambient pressures, which may precipitate spontaneous pneumothorax</div></li><li class="half_rhythm"><div>Radiation exposure</div></li></ul></div><div id="bhd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>When the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known, use of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for early identification of at-risk family members improves diagnostic certainty and reduces costly screening procedures in at-risk members who have not inherited the pathogenic variant.</p><p>Early recognition of clinical manifestations may allow timely intervention and improve outcome. Therefore, clinical surveillance of asymptomatic at-risk relatives for early detection is appropriate.</p><p>See <a href="#bhd.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bhd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="bhd.Genetic_Counseling"><h2 id="_bhd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bhd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Birt-Hogg-Dub&#x000e9; syndrome (BHDS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="bhd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals with BHDS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, and some have BHDS as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLCN</i>.</div></li><li class="half_rhythm"><div>The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown because a sufficient number of parents have not been evaluated for subtle manifestation, nor are there sufficient data on clinically unaffected parents who have been evaluated by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a suspected <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the variant in the proband is identified.</div></li></ul><p>Note: Although some individuals diagnosed with BHDS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has an <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the sibs of the proband are at a 50% risk of inheriting the pathogenic variant.</div></li><li class="half_rhythm"><div>If neither parent has the <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with BHDS is at a 50% risk of inheriting the <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The degree of clinical severity is not predictable.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="bhd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#bhd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with BHDS has the <i>FLCN</i> pathogenic variant or clinical evidence of the disorder, it is likely that mutation of <i>FLCN</i> occurred <i>de novo</i> in the proband. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Testing at-risk asymptomatic family members.</b> Molecular genetic testing of at-risk family members is appropriate in order to identify the need for continued lifelong clinical surveillance. Interpretation of the result is most accurate when an <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Those who have the pathogenic variant require lifelong, regular surveillance. Family members who have not inherited the pathogenic variant and their offspring have risks similar to the general population.</p><p>Early detection of at-risk individuals affects medical management. However, in the absence of an increased risk of developing childhood malignancy, the American Society of Clinical Oncology (<a href="http://www.asco.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ASCO</a>) recommends delaying genetic testing in at-risk individuals until they reach age 18 years and are able to make informed decisions regarding genetic testing [<a class="bk_pop" href="#bhd.REF1">American Society of Clinical Oncology 2003</a>].</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bhd.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for BHDS are possible.</p></div></div><div id="bhd.Resources"><h2 id="_bhd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>BHD Foundation</b></div><div>London </div><div>United Kingdom</div><div><b>Phone:</b> 44(0)20 7193 8921</div><div><b>Email:</b> contact@bhdsyndrome.org</div><div><a href="https://www.bhdsyndrome.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.bhdsyndrome.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Birt-Hogg-Dube%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Birt-Hogg-Dub&#x000e9; Syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=birthoggdubesyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Birt-Hogg-Dub&#x000e9; syndrome</a></div></li><li class="half_rhythm"><div><b>Kidney Cancer Association</b></div><div>PO Box 96503</div><div>Washington DC 20090</div><div><b>Phone:</b> 800-850-9132 (toll-free); 312-436-1455</div><div><b>Fax:</b> 847-332-2978</div><div><b>Email:</b> kidney.cancer@hotmail.com</div><div><a href="http://www.kidneycancer.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kidneycancer.org</a></div></li></ul></div><div id="bhd.Molecular_Genetics"><h2 id="_bhd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bhd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Birt-Hogg-Dube Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1522/table/bhd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bhd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bhd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bhd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bhd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bhd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bhd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bhd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bhd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/201163" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLCN</i></a></td><td headers="hd_b_bhd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=201163" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_bhd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8NFG4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Folliculin</a></td><td headers="hd_b_bhd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/FLCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Folliculin (FLCN) @ LOVD</a></td><td headers="hd_b_bhd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLCN</a></td><td headers="hd_b_bhd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLCN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLCN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bhd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bhd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Birt-Hogg-Dube Syndrome (<a href="/omim/135150,607273" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1522/table/bhd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bhd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/135150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">135150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BIRT-HOGG-DUBE SYNDROME; BHD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607273" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607273</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FOLLICULIN; FLCN</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>FLCN</i> (<i>BHD</i>) was identified by positional cloning by <a class="bk_pop" href="#bhd.REF.nickerson.2002.157">Nickerson et al [2002]</a>. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is highly conserved across species. Human <i>FLCN</i> consists of 14 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1522/#bhd.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figbhdTflcnpathogenicvariantsdiscussed" rid-ob="figobbhdTflcnpathogenicvariantsdiscussed">Table 2</a>. Various pathogenic variants have been identified in families with Birt-Hogg-Dub&#x000e9; syndrome (BHDS). All pathogenic variants predict protein truncation. The most common pathogenic variants are c.1285dupC and c.1285delC, which duplicate or delete a single C nucleotide in a polycytosine tract in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11, suggesting the presence of a hypermutable site [<a class="bk_pop" href="#bhd.REF.schmidt.2005.1023">Schmidt et al 2005</a>].</p><div id="bhd.T.flcn_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>FLCN</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1522/table/bhd.T.flcn_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bhd.T.flcn_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.610_611delGCinsTA</td><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala204Ter</td><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_144997.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_144997<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/entrez/viewer.fcgi?val=NP_659434.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_659434<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1285dupC<br />(1733insC)</td><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His429ProfsTer26</td></tr><tr><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1285delC<br />(1733delC)</td><td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His429ThrfsTer38</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bhd.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p>For more information, see <a href="/books/NBK1522/#bhd.molgen.TA">Table A</a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Folliculin (FLCN) has 579 amino acid residues. A role for folliculin is suggested in regulation of 5' AMP-activated protein kinase (AMPK) and activation of the mTOR signaling pathway. Specifically, folliculin forms a complex with folliculin interacting protein 1 or 2 (encoded by <i>FNIP1</i> or <i>FNIP2</i>) and the FLCN-FNIP complex binds to AMPK [<a class="bk_pop" href="#bhd.REF.baba.2006.15552">Baba et al 2006</a>, <a class="bk_pop" href="#bhd.REF.hasumi.2008.60">Hasumi et al 2008</a>, <a class="bk_pop" href="#bhd.REF.takagi.2008.5339">Takagi et al 2008</a>]. Recent studies suggest that loss of FLCN expression leads to activation of the AMPK/PGC-1&#x003b1;/OXPHOS/HIF signaling axis [<a class="bk_pop" href="#bhd.REF.klomp.2010.59">Klomp et al 2010</a>]. Loss of FLCN constitutively activates AMPK, resulting in PGC-1&#x003b1;-mediated mitochondrial biogenesis and increased ROS production [<a class="bk_pop" href="#bhd.REF.yan.2014.2640">Yan et al 2014</a>]. It is hypothesized that FLCN inhibits tumorigenesis by preventing AMPK-dependent HIF activation and the subsequent Warburg metabolic transformation [<a class="bk_pop" href="#bhd.REF.yan.2014.2640">Yan et al 2014</a>]. Loss of FLCN induces an AMPK-HIF-dependent metabolic reprogramming favoring tumor progression.</p><p>FLCN is highly expressed in a variety of tissues including skin and skin appendages, type 1 pneumocytes, and distal nephrons of the kidney [<a class="bk_pop" href="#bhd.REF.warren.2004.998">Warren et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Germline pathogenic variants in <i>FLCN</i> &#x02013; as well as somatic variants and <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> in tumor tissue &#x02013; suggest that loss of function of the folliculin protein is the basis of tumor formation in BHDS [<a class="bk_pop" href="#bhd.REF.vocke.2005.931">Vocke et al 2005</a>]. Reduced expression of folliculin in renal tumors from individuals with BHDS supports its role in tumor suppression [<a class="bk_pop" href="#bhd.REF.warren.2004.998">Warren et al 2004</a>].</p><div id="bhd.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Acquired nucleotide variants in <i>FLCN</i> have been identified in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> clear cell renal cell carcinoma [<a class="bk_pop" href="#bhd.REF.da_silva.2003.820">da Silva et al 2003</a>, <a class="bk_pop" href="#bhd.REF.khoo.2003.4583">Khoo et al 2003</a>] and colon cancer [<a class="bk_pop" href="#bhd.REF.kahnoski.2003.511">Kahnoski et al 2003</a>, <a class="bk_pop" href="#bhd.REF.shin.2003.364">Shin et al 2003</a>], without other associated tumors characteristic of the heritable disease.</p><ul><li class="half_rhythm"><div><i>FLCN</i> pathogenic variants have been identified in two cell lines with MSI [<a class="bk_pop" href="#bhd.REF.shin.2003.364">Shin et al 2003</a>].</div></li><li class="half_rhythm"><div>In one study, 16% of MSI <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> colorectal carcinoma harbored pathogenic variants in the poly C8 track of <i>FLCN</i> [<a class="bk_pop" href="#bhd.REF.shin.2003.364">Shin et al 2003</a>].</div></li><li class="half_rhythm"><div>An independent English study found that somatic frameshifting variants in the <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 C(8) mononucleotide tract of <i>FLCN</i> were detected in 23% of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> colorectal cancers with <a class="def" href="/books/n/gene/glossary/def-item/microsatellite/">microsatellite</a> instability [<a class="bk_pop" href="#bhd.REF.nahorski.2010.385">Nahorski et al 2010</a>].</div></li><li class="half_rhythm"><div>Two <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>FLCN</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported in colorectal cancer cell lines.</div></li></ul><p>Further studies are needed to investigate the role of folliculin in colorectal carcinogenesis.</p></div><div id="bhd.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>BHDS-associated renal tumors have distinct <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression and <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> characteristics as compared to <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> renal oncocytoma and chromophobe RCC [<a class="bk_pop" href="#bhd.REF.klomp.2010.59">Klomp et al 2010</a>]. BHDS-derived kidney tumors have high expression of mitochondria- and oxidative phosphorylation-associated genes and deregulation of the PGC-1&#x003b1;-TFAM signaling axis. In addition, loss of <i>FLCN</i> expression is also associated with increased nuclear mitochondrial gene expression [<a class="bk_pop" href="#bhd.REF.klomp.2010.59">Klomp et al 2010</a>].</p></div></div><div id="bhd.References"><h2 id="_bhd_References_">References</h2><div id="bhd.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bhd.REF1">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. 2003. [<a href="/pubmed/12692171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12692171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF2">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <a href="http://jco.ascopubs.org/content/28/5/893.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2010. Accessed 2-20-19.</div></li></ul></div><div id="bhd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.american_society_of_clinical_oncology.2003.2397">American Society of Clinical Oncology.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:2397–406.</span> [<a href="/pubmed/12692171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12692171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.baba.2006.15552">Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR Jr, Linehan WM, Schmidt LS, Zbar B. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2006;<span class="ref-vol">103</span>:15552–7.</span> [<a href="/pmc/articles/PMC1592464/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1592464</span></a>] [<a href="/pubmed/17028174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17028174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.chung.1996.365">Chung JY, Ramos-Caro FA, Beers B, Ford MJ, Flowers F. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. <span><span class="ref-journal">Int J Dermatol. </span>1996;<span class="ref-vol">35</span>:365–7.</span> [<a href="/pubmed/8734663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8734663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.claessens.2010.583">Claessens T, Weppler SA, van Geel M, Creytens D, Vreeburg M, Wouters B, van Steensel MA. Neuroendocrine carcinoma in a patient with Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Nat Rev Urol. </span>2010;<span class="ref-vol">7</span>:583–7.</span> [<a href="/pubmed/20842188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20842188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.cocciolone.2010.1316">Cocciolone RA, Crotty KA, Andrews L, Haass NK, Moloney FJ. Multiple desmoplastic melanomas in Birt-Hogg-Dub&#x000e9; syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. <span><span class="ref-journal">Arch Dermatol. </span>2010;<span class="ref-vol">146</span>:1316–8.</span> [<a href="/pubmed/21079084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21079084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.da_silva.2003.820">da Silva NF, Gentle D, Hesson LB, Morton DG, Latif F, Maher ER. Analysis of the Birt-Hogg-Dub&#x000e9; (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:820–4.</span> [<a href="/pmc/articles/PMC1735328/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735328</span></a>] [<a href="/pubmed/14627671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14627671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.daniel.2000.327">Daniel R, Teba L. Spontaneous pneumothorax and alpha 1-antitrypsin deficiency. <span><span class="ref-journal">Respir Care. </span>2000;<span class="ref-vol">45</span>:327–9.</span> [<a href="/pubmed/10771802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10771802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.drummond.2002.301">Drummond C, Grigoris I, Dutta B. Birt-Hogg-Dub&#x000e9; syndrome and multinodular goitre. <span><span class="ref-journal">Australas J Dermatol. </span>2002;<span class="ref-vol">43</span>:301–4.</span> [<a href="/pubmed/12423440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12423440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.flume.2005.720">Flume PA, Strange C, Ye X, Ebeling M, Hulsey T, Clark LL. Pneumothorax in cystic fibrosis. <span><span class="ref-journal">Chest. </span>2005;<span class="ref-vol">128</span>:720–8.</span> [<a href="/pubmed/16100160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16100160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.fontcuberta.2011.143">Fontcuberta IC, Salom&#x000e3;o DR, Quiram PA, Pulido JS. Choroidal melanoma and lid fibrofoliculomas in Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Ophthalmic Genet. </span>2011;<span class="ref-vol">32</span>:143–6.</span> [<a href="/pubmed/21401403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21401403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.gambichler.2000.856">Gambichler T, Wolter M, Altmeyer P, Hoffman K. Treatment of Birt-Hogg-Dub&#x000e9; syndrome with erbium:YAG laser. <span><span class="ref-journal">J Am Acad Dermatol. </span>2000;<span class="ref-vol">43</span>:856–8.</span> [<a href="/pubmed/11050594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11050594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.godbolt.2003.52">Godbolt AM, Robertson IM, Weedon D. Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Australas J Dermatol. </span>2003;<span class="ref-vol">44</span>:52–6.</span> [<a href="/pubmed/12581083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12581083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.graham.2005.39">Graham RB, Nolasco M, Peterlin B, Garcia CK. Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2005;<span class="ref-vol">172</span>:39–44.</span> [<a href="/pubmed/15805188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.hasumi.2008.60">Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M, Valera VA, Linehan WM, Schmidt LS. Identification and characterization of a novel folliculin-interacting protein FNIP2. <span><span class="ref-journal">Gene. </span>2008;<span class="ref-vol">415</span>:60–7.</span> [<a href="/pmc/articles/PMC2727720/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2727720</span></a>] [<a href="/pubmed/18403135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18403135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.jacob.2001.98">Jacob CI, Dover JS. Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. <span><span class="ref-journal">Arch Dermatol. </span>2001;<span class="ref-vol">137</span>:98–99.</span> [<a href="/pubmed/11176677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11176677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.kahle.2001.43">Kahle B, Hellwig S, Schulz T. Multiple mantleomas in Birt-Hogg-Dub&#x000e9; syndrome: successful therapy with CO2 laser. <span><span class="ref-journal">Hautarzt. </span>2001;<span class="ref-vol">52</span>:43–6.</span> [<a href="/pubmed/11220238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11220238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.kahnoski.2003.511">Kahnoski K, Khoo SK, Nassif NT, Chen J, Lobo GP, Segelov E, Teh BT. Alterations of the Birt-Hogg-Dub&#x000e9; gene (BHD) in sporadic colorectal tumours. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:511–5.</span> [<a href="/pmc/articles/PMC1735520/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735520</span></a>] [<a href="/pubmed/12843323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12843323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.khoo.2002.906">Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Levy R, Ferlicot S, Wolkenstein P, Hammel P, Bergerheim U, Hedblad MA, Bradley M, Teh BT, Nordenskjold M, Richard S. Clinical and genetic studies of Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:906–12.</span> [<a href="/pmc/articles/PMC1757219/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757219</span></a>] [<a href="/pubmed/12471204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.khoo.2003.4583">Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjold M, Teh BT. Inactivation of BHD in sporadic renal tumors. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:4583–7.</span> [<a href="/pubmed/12907635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12907635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.klomp.2010.59">Klomp JA, Petillo D, Niemi NM, Dykema KJ, Chen J, Yang XJ, S&#x000e4;&#x000e4;f A, Zickert P, Aly M, Bergerheim U, Nordenskj&#x000f6;ld M, Gad S, Giraud S, Denoux Y, Yonneau L, M&#x000e9;jean A, Vasiliu V, Richard S, MacKeigan JP, Teh BT, Furge KA. Birt-Hogg-Dub&#x000e9; renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. <span><span class="ref-journal">BMC Med Genomics. </span>2010;<span class="ref-vol">3</span>:59.</span> [<a href="/pmc/articles/PMC3012009/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3012009</span></a>] [<a href="/pubmed/21162720" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21162720</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.kluger.2010.527">Kluger N, Giraud S, Coupier I, Avril MF, Dereure O, Guillot B, Richard S, Bessis D. Birt-Hogg-Dub&#x000e9; syndrome: clinical and genetic studies of 10 French families. <span><span class="ref-journal">Br J Dermatol. </span>2010;<span class="ref-vol">162</span>:527–37.</span> [<a href="/pubmed/19785621" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19785621</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.kumasaka.2014.100">Kumasaka T, Hayashi T, Mitani K, Kataoka H, Kikkawa M, Tobino K, Kobayashi E, Gunji Y, Kunogi M, Kurihara M, Seyama K. Characterization of pulmonary cysts in Birt-Hogg-Dub&#x000e9; syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients. <span><span class="ref-journal">Histopathology. </span>2014;<span class="ref-vol">65</span>:100–10.</span> [<a href="/pmc/articles/PMC4237186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4237186</span></a>] [<a href="/pubmed/24393238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24393238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.kunogi.2010.281">Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S, Hino O, Takahashi K, Seyama K. Clinical and genetic spectrum of Birt&#x02013;Hogg&#x02013;Dub&#x000e9; syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:281–7.</span> [<a href="/pmc/articles/PMC2981024/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2981024</span></a>] [<a href="/pubmed/20413710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20413710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.lindor.2001.653">Lindor NM, Hand J, Burch PA, Gibson LE. Birt-Hogg-Dube syndrome: an autosomal dominant disorder with predisposition to cancers of the kidney, fibrofolliculomas, and focal cutaneous mucinosis. <span><span class="ref-journal">Int J Dermatol. </span>2001;2001;<span class="ref-vol">40</span>:653–6.</span> [<a href="/pubmed/11737429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11737429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.lindor.2012.13">Lindor NM, Kasperbauer J, Lewis JE, Pittelkow M. Birt-Hogg-Dube syndrome presenting as multiple oncocytic parotid tumors. <span><span class="ref-journal">Hered Cancer Clin Pract. </span>2012;<span class="ref-vol">10</span>:13.</span> [<a href="/pmc/articles/PMC3492097/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3492097</span></a>] [<a href="/pubmed/23050938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23050938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.linehan.2005.2">Linehan WM, Grubb RL, Coleman JA, Zbar B, Walther MM. The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management. <span><span class="ref-journal">BJU Int. </span>2005;<span class="ref-vol">95</span> Suppl 2:2–7.</span> [<a href="/pubmed/15720328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15720328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.liu.2000.1120">Liu V, Kwan T, Page EH. Parotid oncocytoma in the Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">J Am Acad Dermatol. </span>2000;<span class="ref-vol">43</span>:1120–2.</span> [<a href="/pubmed/11100034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11100034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.maff_.2011.345">Maff&#x000e9; A, Toschi B, Circo G, Giachino D, Giglio S, Rizzo A, Carloni A, Poletti V, Tomassetti S, Ginardi C, Ungari S, Genuardi M. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dub&#x000e9; syndrome ascertained for non-cutaneous manifestations. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">79</span>:345–54.</span> [<a href="/pubmed/20618353" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20618353</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.mendez.2004.1028">Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. <span><span class="ref-journal">Chest. </span>2004;<span class="ref-vol">125</span>:1028–32.</span> [<a href="/pubmed/15006964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15006964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.moore.2005.240">Moore LE, Wilson RT, Campleman SL. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. <span><span class="ref-journal">Cancer Invest. </span>2005;<span class="ref-vol">23</span>:240–55.</span> [<a href="/pubmed/15945510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15945510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.motaburgos.2013.323">Mota-Burgos A, Acosta EH, M&#x000e1;rquez FV, Mendiola M, Herrera-Ceballos E. Birt-Hogg-Dub&#x000e9; syndrome in a patient with melanoma and a novel mutation in the FCLN gene. <span><span class="ref-journal">Int J Dermatol. </span>2013;<span class="ref-vol">52</span>:323–6.</span> [<a href="/pubmed/23414156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23414156</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.nadershahi.1997.496">Nadershahi NA, Wescott WB, Egbert B. Birt-Hogg-Dub&#x000e9; syndrome: a review and presentation of the first case with oral lesions. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol Oral Radiol Endod. </span>1997;<span class="ref-vol">83</span>:496–500.</span> [<a href="/pubmed/9127384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9127384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.nahorski.2010.385">Nahorski MS, Lim DH, Martin L, Gille JJ, McKay K, Rehal PK, Ploeger HM, van Steensel M, Tomlinson IP, Latif F, Menko FH, Maher ER. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:385–90.</span> [<a href="/pubmed/20522427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20522427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.nickerson.2002.157">Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Cancer Cell. </span>2002;<span class="ref-vol">2</span>:157–64.</span> [<a href="/pubmed/12204536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12204536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.painter.2005.522">Painter JN, Tapanainen H, Somer M, Tukiainen P, Aittomaki K. A 4-bp deletion in the Birt-Hogg-Dub&#x000e9; gene (FLCN) causes dominantly inherited spontaneous pneumothorax. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:522–7.</span> [<a href="/pmc/articles/PMC1196403/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196403</span></a>] [<a href="/pubmed/15657874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15657874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.palmirotta.2008.382">Palmirotta R, Donati P, Savonarola A, Cota C, Ferroni P, Guadagni F. Birt-Hogg-Dub&#x000e9; (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene. <span><span class="ref-journal">Eur J Dermatol. </span>2008;<span class="ref-vol">18</span>:382–6.</span> [<a href="/pubmed/18573707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18573707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.pavlovich.2005.1482">Pavlovich CP, Grubb RL 3rd, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. Evaluation and management of renal tumors in the Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">J Urol. </span>2005;<span class="ref-vol">173</span>:1482–6.</span> [<a href="/pubmed/15821464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15821464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.renfree.2012.792">Renfree KJ, Lawless KL. Multiple neurilemmomas in Birt-Hogg-Dub&#x000e9; syndrome: case report. <span><span class="ref-journal">J Hand Surg Am. </span>2012;<span class="ref-vol">37</span>:792–4.</span> [<a href="/pubmed/22326190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22326190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.schmidt.2005.1023">Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:1023–33.</span> [<a href="/pmc/articles/PMC1196440/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196440</span></a>] [<a href="/pubmed/15852235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15852235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.schulz.1999.55">Schulz T, Hartschuh W. Birt-Hogg-Dub&#x000e9; syndrome and Hornstein-Knickenberg syndrome are the same. Different sectioning technique as the cause of different histology. <span><span class="ref-journal">J Cutan Pathol. </span>1999;<span class="ref-vol">26</span>:55–61.</span> [<a href="/pubmed/10189247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10189247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.sempau.2010.637">Sempau L, Ruiz I, Gonz&#x000e1;lez-Mor&#x000e1;n A, Susanna X, Hansen TV. New mutation in the Birt Hogg Dube gene. <span><span class="ref-journal">Actas Dermosifiliogr. </span>2010;<span class="ref-vol">101</span>:637–40.</span> [<a href="/pubmed/20858390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20858390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.shin.2003.364">Shin JH, Shin YK, Ku JL, Jeong SY, Hong SH, Park SY, Kim WH, Park JG. Mutations of the Birt-Hogg-Dub&#x000e9; (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:364–7.</span> [<a href="/pmc/articles/PMC1735471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735471</span></a>] [<a href="/pubmed/12746401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12746401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.stamatakis.2013.397">Stamatakis L, Metwalli AR, Middelton LA, Marston Linehan W. Diagnosis and management of BHD-associated kidney cancer. <span><span class="ref-journal">Fam Cancer. </span>2013;<span class="ref-vol">12</span>:397–402.</span> [<a href="/pmc/articles/PMC4175415/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4175415</span></a>] [<a href="/pubmed/23703644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23703644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.takagi.2008.5339">Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G, Zhang D, Abe M, Hagiwara Y, Takahashi K, Hino O. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. <span><span class="ref-journal">Oncogene. </span>2008;<span class="ref-vol">27</span>:5339–47.</span> [<a href="/pubmed/18663353" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18663353</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.toro.1999.1195">Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML. Birt-Hogg-Dub&#x000e9; syndrome: a novel marker of kidney neoplasia. <span><span class="ref-journal">Arch Dermatol. </span>1999;<span class="ref-vol">135</span>:1195–202.</span> [<a href="/pubmed/10522666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10522666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.toro.2007.1044">Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2007;<span class="ref-vol">175</span>:1044–53.</span> [<a href="/pmc/articles/PMC1899269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1899269</span></a>] [<a href="/pubmed/17322109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17322109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.toro.2008.321">Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub&#x000e9; syndrome: a new series of 50 families and a review of published reports. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:321–31.</span> [<a href="/pmc/articles/PMC2564862/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564862</span></a>] [<a href="/pubmed/18234728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18234728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.vincent.2003.717">Vincent A, Farley M, Chan E, James WD. Birt-Hogg-Dub&#x000e9; syndrome: two patients with neural tissue tumors. <span><span class="ref-journal">J Am Acad Dermatol. </span>2003;<span class="ref-vol">49</span>:717–9.</span> [<a href="/pubmed/14512924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14512924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.vocke.2005.931">Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dub&#x000e9;-associated renal tumors. <span><span class="ref-journal">J Natl Cancer Inst. </span>2005;<span class="ref-vol">97</span>:931–5.</span> [<a href="/pubmed/15956655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15956655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.walter.1997.359">Walter P, Kirchhof B, Korge B, Heimann K. Flecked chorioretinopathy associated with Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>1997;<span class="ref-vol">235</span>:359–61.</span> [<a href="/pubmed/9202964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9202964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.warren.2004.998">Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dub&#x000e9; gene mRNA in normal and neoplastic human tissues. <span><span class="ref-journal">Mod Pathol. </span>2004;<span class="ref-vol">17</span>:998–1011.</span> [<a href="/pubmed/15143337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15143337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.welsch.2005.668">Welsch MJ, Krunic A, Medenica MM. Birt-Hogg-Dub&#x000e9; Syndrome. <span><span class="ref-journal">Int J Dermatol. </span>2005;<span class="ref-vol">44</span>:668–73.</span> [<a href="/pubmed/16101870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16101870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.yan.2014.2640">Yan M, Gingras MC, Dunlop EA, Nou&#x000eb;t Y, Dupuy F, Jalali Z, Possik E, Coull BJ, Kharitidi D, Dydensborg AB, Faubert B, Kamps M, Sabourin S, Preston RS, Davies DM, Roughead T, Chotard L, van Steensel MA, Jones R, Tee AR, Pause A. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. <span><span class="ref-journal">J Clin Invest. </span>2014;<span class="ref-vol">124</span>:2640–50.</span> [<a href="/pmc/articles/PMC4038567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4038567</span></a>] [<a href="/pubmed/24762438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24762438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bhd.REF.zbar.2002.393">Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, Duray P, Gabril F, Greenberg C, Merino MJ, Toro J, Linehan WM. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dub&#x000e9; syndrome. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2002;<span class="ref-vol">11</span>:393–400.</span> [<a href="/pubmed/11927500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11927500</span></a>]</div></li></ul></div></div><div id="bhd.Chapter_Notes"><h2 id="_bhd_Chapter_Notes_">Chapter Notes</h2><div id="bhd.Author_History"><h3>Author History</h3><p>Manop Pithukpakorn, MD; Mahidol University (2006-2008)<br />Jorge R Toro, MD (2006-present)</p></div><div id="bhd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 September 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 February 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>30 November 2005 (jt) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Birt-Hogg-Dub&#x000e9; Syndrome" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1522</span><span class="label">PMID: <a href="/pubmed/20301695" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301695</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/biotin/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bpes/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1522&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1522/?report=reader">PubReader</a></li><li><a href="/books/NBK1522/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1522" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1522" style="display:none" title="Cite this Page"><div class="bk_tt">Toro JR. Birt-Hogg-Dubé Syndrome. 2006 Feb 27 [Updated 2014 Aug 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1522/pdf/Bookshelf_NBK1522.pdf">PDF version of this page</a> (463K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bhd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bhd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bhd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bhd.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bhd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bhd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bhd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bhd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bhd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bhd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bhd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=201163[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLCN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1522+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1475308" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1475308" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1475308" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1475308" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29157599" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts.</a><span class="source">[J Dermatol Sci. 2018]</span><div class="brieflinkpop offscreen_noflow">Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Iwabuchi C, Ebana H, Ishiko A, Negishi A, Mizobuchi T, Kumasaka T, Kurihara M, Seyama K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Dermatol Sci. 2018 Jan; 89(1):77-84. Epub 2017 Nov 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31266032" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome.</a><span class="source">[Respiration. 2019]</span><div class="brieflinkpop offscreen_noflow">The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Torricelli E, Occhipinti M, Cavigli E, Tancredi G, Rosi E, Rossi C, Bonaguro M, Candita L, Papi L, Novelli L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Respiration. 2019; 98(2):125-132. Epub 2019 Jul 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26608100" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.</a><span class="source">[Int J Urol. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hasumi H, Baba M, Hasumi Y, Furuya M, Yao M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Urol. 2016 Mar; 23(3):204-10. Epub 2015 Nov 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28326182" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Birt-Hogg-Dubé syndrome: a case report and a review of the literature.</a><span class="source">[Eur Clin Respir J. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Birt-Hogg-Dubé syndrome: a case report and a review of the literature.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jensen DK, Villumsen A, Skytte AB, Madsen MG, Sommerlund M, Bendstrup E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur Clin Respir J. 2017; 4(1):1292378. Epub 2017 Feb 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20618353" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations.</a><span class="source">[Clin Genet. 2011]</span><div class="brieflinkpop offscreen_noflow">Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Maffé A, Toschi B, Circo G, Giachino D, Giglio S, Rizzo A, Carloni A, Poletti V, Tomassetti S, Ginardi C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Genet. 2011 Apr; 79(4):345-54. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301695" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301695" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04146d75f66d18aa19d4c3">Birt-Hogg-Dubé Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Birt-Hogg-Dubé Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:01:17-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C7702E03F7D81000000000B1B03BF&amp;ncbi_session=CE8C7702E04146D1_2843SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1522%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1522&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1522/&amp;ncbi_pagename=Birt-Hogg-Dubé Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C7702E04146D1_2843SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>